ASML

In the end, you can only hope that you don't regret it. European shares in the summer sale.

Today I bought the last tranche of Carl Zeiss Meditec $AFX (-3,72 %) today. The reason is of course that I am still convinced of the company, but nobody can say how long it will be before the share comes back to life.

It could probably go down even further, but I have decided not to buy any more from now on as the position is large enough and otherwise my risk management will no longer work.

Overall, I have increased my position size from around 1% to just over 3%, which already represents a clear commitment to a German company, which is known to be particularly volatile.

The same applies to L'Oreal $OR (+0,86 %) here, too, I have finished buying with a buy-in of €365 and have reached a position size that is already approaching the 4% portfolio weighting. The shares will probably continue to fall for the time being, which I will simply have to hold on to.

I would now rather concentrate on other opportunities such as Thermo Fisher $TMO (+0,85 %) where I have already doubled down this month. Here, however, I can well imagine buying significantly more if prices fall.

It cannot be ruled out that, if the market as a whole weakens, LVMH $MC (-1,31 %) and $ASML (+2,27 %) a first purchase could take place. With the four stocks already mentioned here (+ $NOVO B (-2,36 %) ) mentioned here, I believe that the potential of Western European equities has already been fully exhausted.

It's just a difficult case. Europe is currently more attractive than ever before compared to the hot American market. Either you can seize the opportunity of the decade NOW and bet on a recovery of the European economy, then the champagne corks will pop here in two years' time. Or there will be a complete implosion of the European economy (and then the double-digit losses in the portfolio will be the least of our problems)

Reallocation in the portfolio:

Out went $AFX (-3,72 %)

New in $ASML (+2,27 %)

The decision was not easy, as I am still convinced of Meditec, but unfortunately the market simply sees things differently at the moment.

I see more upside for ASML as a shovel seller and more downside for Meditec with the possible tariff war between USA - Europe - China ( Asia accounts for a third of sales in 2023 according to Trading View )

Meditec remains on the watch while I wait for the quarterly figures on 11.12

$ASML (+2,27 %) - get in now or wait?🤔

What do you think? When is the best time to $ASML (+2,27 %)
to get in?

How do you rate the long-term potential of this tech giant in the semiconductor market?

Also: What are your predictions for the share's performance up to 2025?📈

I'm looking forward to your opinions 👇

#ASML
#Investieren
#Halbleiter
#Aktien-analysis #Prognose2025

I set up a custody account with Scalable Capital last week.

In addition to my cash flow depotwhich currently pays me a dividend of €709.45 next year (see picture), I will set up a savings plan custody account there.

This savings plan custody account will have a term of 20 years+.

I will pay in €495 per month and divide it between 15 companies as follows:

$GOOGL (-5,09 %) - 33€

$AMZN (-1,73 %) - 33€

$AAPL (+0,74 %) -33€

$ASML (+2,27 %) - 33€

$FAST (+1,1 %) - 33€

$JNJ (+2,57 %) - 33€

$MC (-1,31 %) - 33€

$MCD (-0,63 %) - 33€

$MSFT (-0,11 %) - 33€

$NOVO B (-2,36 %) - 33€

$PEP (+0,95 %) - 33€

$PG (+1,88 %) - 33€

$UNP (+2,32 %) - 33€

$UNH (+0,16 %) - 33€

$V (+1,33 %) - 33€

The savings plans will be executed for the first time on Monday and then continue on a monthly basis.

I will post a monthly update here

Pair of chips taken from the table.

Then slowly moves into candidates like $ASML (+2,27 %) , $MC (-1,31 %) , $NOVO B (-2,36 %)

Profit taking:

Reallocation of 40% into $VWCE (+0,97 %) , 10% $IGLN (+1,28 %) and 50% in individual stocks $8035 (-0,36 %) , $GOOG (-4,99 %) , $ASML (+2,27 %) , $MSFT (-0,11 %)